TY  - JOUR
T1  - HYpotension as a complication of promazine therapy
AU  - KAPLAN NM
Y1  - 1959/02/01
N1  - 10.1001/archinte.1959.00270020047005
JO  - A.M.A. Archives of Internal Medicine
SP  - 219
EP  - 223
VL  - 103
IS  - 2
N2  - The use of promazine as a tranquilizing agent in the treatment of a variety of disease states has achieved widespread currency. Recent reports have appeared concerning its efficacy in the management of patients with both acute and chronic mental disturbances,1,2 including alcoholism3,4 and delerium tremens,5 as well as its use as a predelivery sedative.6A prime factor leading to the extensive use of this drug has been the generally accepted belief that removal of the chloride ion from chlorpromazine leads to diminished toxicity without loss of therapeutic potency. It has been frequently stated that use of the drug is not attended by serious side-effects.1-6 However, isolated reports of toxic complications, including agranulocytosis,7-9 convulsions, and dermatitis,10 have appeared. Another complication, marked hypotension, which is more properly considered an anticipated pharmacologic effect, has been observed 3,10 but is said to be "slight," 6 "moderate," 1 and, in fact, "not encountered."5 Though mention
SN  - 0888-2479
M3  - doi: 10.1001/archinte.1959.00270020047005
UR  - http://dx.doi.org/10.1001/archinte.1959.00270020047005
ER  -